Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1994 Feb 1;150(3):375–376.

Paranoid psychosis induced by oxymetazoline nasal spray.

B Ticoll 1, G Shugar 1
PMCID: PMC1486156  PMID: 8293377

Full text

PDF
375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell D. S. The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry. 1973 Jul;29(1):35–40. doi: 10.1001/archpsyc.1973.04200010020003. [DOI] [PubMed] [Google Scholar]
  2. Blackwood G. W. Severe psychological disturbance resulting from abuse of nasal decongestants. Scott Med J. 1982 Apr;27(2):175–176. doi: 10.1177/003693308202700212. [DOI] [PubMed] [Google Scholar]
  3. Boffi B. V., Klerman G. L. Manic psychosis associated with appetite suppressant medication, phenylpropanolamine. J Clin Psychopharmacol. 1989 Aug;9(4):308–309. doi: 10.1097/00004714-198908000-00022. [DOI] [PubMed] [Google Scholar]
  4. Craig D. F. Psychosis with Vicks Formula 44-D abuse. CMAJ. 1992 Apr 1;146(7):1199–1200. [PMC free article] [PubMed] [Google Scholar]
  5. Derlet R. W., Heischober B. Methamphetamine. Stimulant of the 1990s? West J Med. 1990 Dec;153(6):625–628. [PMC free article] [PubMed] [Google Scholar]
  6. Edlund M. Intravenous nasal decongestant use. J Clin Psychiatry. 1989 Oct;50(10):392–392. [PubMed] [Google Scholar]
  7. Herridge C. F., a'Brook M. F. Ephedrine psychosis. Br Med J. 1968 Apr 20;2(5598):160–160. doi: 10.1136/bmj.2.5598.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kane F. J., Jr, Green B. Q. Psychotic episodes associated with the use of common proprietary decongestants. Am J Psychiatry. 1966 Oct;123(4):484–487. doi: 10.1176/ajp.123.4.484. [DOI] [PubMed] [Google Scholar]
  9. Lake C. R., Quirk R. S. CNS stimulants and the look-alike drugs. Psychiatr Clin North Am. 1984 Dec;7(4):689–701. [PubMed] [Google Scholar]
  10. Lieberman J. A., Kinon B. J., Loebel A. D. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull. 1990;16(1):97–110. doi: 10.1093/schbul/16.1.97. [DOI] [PubMed] [Google Scholar]
  11. McIntyre D. Letter: Psychosis due to nasal decongestant abuse. Br J Psychiatry. 1976 Jul;129:93–94. doi: 10.1192/bjp.129.1.93a. [DOI] [PubMed] [Google Scholar]
  12. Robinson T. E., Becker J. B., Moore C. J., Castañeda E., Mittleman G. Enduring enhancement in frontal cortex dopamine utilization in an animal model of amphetamine psychosis. Brain Res. 1985 Sep 23;343(2):374–377. doi: 10.1016/0006-8993(85)90760-7. [DOI] [PubMed] [Google Scholar]
  13. Snow S. S., Logan T. P., Hollender M. H. Nasal spray 'addiction' and psychosis: a case report. Br J Psychiatry. 1980 Mar;136:297–299. doi: 10.1192/bjp.136.3.297. [DOI] [PubMed] [Google Scholar]
  14. Söderman P., Sahlberg D., Wiholm B. E. Näsdroppar kan framkalla cerebrala reaktioner hos barn. Lakartidningen. 1983 Sep 14;80(37):3286–3287. [PubMed] [Google Scholar]
  15. Whitehouse A. M., Duncan J. M. Ephedrine psychosis rediscovered. Br J Psychiatry. 1987 Feb;150:258–261. doi: 10.1192/bjp.150.2.258. [DOI] [PubMed] [Google Scholar]
  16. Zetterström T., Sharp T., Marsden C. A., Ungerstedt U. In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J Neurochem. 1983 Dec;41(6):1769–1773. doi: 10.1111/j.1471-4159.1983.tb00893.x. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES